Tesamorelin

Description

Overview A stabilized growth hormone releasing hormone analogue supplied as lyophilized powder in sealed vial format. Available at 2.5mg and 5mg. Commonly sourced alongside Sermorelin 15mg, the unmodified sequence it is compared against in degradation work. Supplied for controlled in vitro work by qualified laboratory personnel.

Research Background & Mechanistic Focus Tesamorelin is a GHRH analogue carrying a trans-3-hexenoyl modification at the N-terminus. That single structural change is the entire point of the molecule from a research standpoint, because it substantially slows enzymatic degradation relative to the unmodified sequence while preserving receptor activity. This makes it the standard comparator when investigators want to isolate the variable of peptide stability rather than receptor affinity. Common laboratory contexts include side-by-side degradation kinetics against Sermorelin, GHRH receptor binding characterization, and analytical work on the modified terminus itself.

Structural Information Classification: Stabilized GHRH analog peptide Form: Lyophilized vial presentation Catalog Strengths: 2.5mg, 5mg

Research Applications Used in controlled laboratory settings for receptor-signaling models, comparative pathway analysis, presentation or stability work where applicable, and other non-clinical analytical workflows consistent with authorized research use.

Specifications Research-grade material supplied in lyophilized vial presentation at selected catalog variants. Intended for controlled laboratory handling and analytical preparation only.

Handling & Use Conditions Allow the vial to equilibrate before opening. Reconstitute only under controlled laboratory conditions using appropriate technique. Avoid vigorous agitation, repeated freeze-thaw exposure, and unnecessary environmental exposure during handling.

Storage & Stability Store refrigerated or frozen according to laboratory protocol, protected from light and repeated freeze-thaw cycling. Reconstituted material should be stored only under controlled conditions appropriate for short-term analytical use.

Sourcing Statement RawBiotix research compounds are sourced through U.S.-based supply and verified through independent analytical testing. Minimum 98% purity. Certificates of Analysis available upon request.

Disclaimer For laboratory research use only. Not for human consumption, therapeutic, or diagnostic purposes.